Canadian AIDS Treatment Information Exchange
click here to return to CATIE main menu
DonateNow

SIDE EFFECTS: Protection from nuke side effects

TreatmentUpdate 132 - 2002 December ; Volume 14 Issue 9
Hosein SR
click here for french langage version of article

Nucleoside analogues (nukes or NRTIs) such as AZT, d4T and ddI may be associated with a number of side effects, including the following:

Some researchers think that these problems occur because nukes damage the energy-producing parts of cells called "mitochondria" (Mt). Large numbers of damaged or malfunctioning Mt produce lactic acid (lactate). When high levels of lactic acid in the blood occur, this is known as "lactic acidosis." Generally, this condition is uncommon in PHAs. People with hepatitis B or C are at increased risk for developing lactic acidosis. Symptoms of lactic acidosis include the following:

The following blood tests help identify lactic acidosis:

If left untreated, lactic acidosis can be deadly.

Doctors in Barcelona, Spain, have been studying remedies for lactic acidosis in PHAs.

Study details

The doctors enrolled 9 subjects (2 female, 7 males) for their study of this rare complication between March 2001 and July 2002. All subjects had symptoms of lactic acidosis as well as the following profile:

Upon entry to the hospital, all subjects stopped using nukes and reduced their sugar intake. Water was given to them intravenously. They also received the following supplements:

Given this treatment, 8 of the 9 PHAs had their symptoms of lactic acidosis clear within a week. The ninth PHA's lymphoma in the kidney eventually resulted in death. Levels of lactate in the blood took more than a week to fall.

If this mix of B-vitamins and antioxidants is useful in the treatment of lactic acidosis, we wonder if smaller doses may also be helpful in preventing this complication. Researchers in Vancouver, British Columbia, are testing a combination of two B-vitamins in nuke users to find out if this strategy is effective.

REFERENCE

Bachs MR, Soler A, Villa C, et al. Focus on lactic acidosis therapy in HIV patients under nucleoside analogue reverse transcriptase inhibitors (NRTIs). Sixth International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow. Poster 125.

20021210
CATE13201


Copyright © 2002 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284  http://www.catie.ca.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.